⚠️ “These Tablets Can Cause Blood Clots and Heart Attacks” — What Does This Mean?
This headline can refer to a real medication warning, but it is dangerously incomplete because it doesn’t identify the tablets.
One important example is the class of medicines called JAK inhibitors, including tofacitinib (Xeljanz), baricitinib (Olumiant), and upadacitinib (Rinvoq). The FDA requires prominent warnings about increased risks of serious cardiovascular events such as heart attack or stroke, blood clots, cancer and death with these medicines. (U.S. Food and Drug Administration)
🚨 Symptoms of a possible blood clot or heart attack
Anyone taking a medication with such a warning should seek emergency medical attention for symptoms such as:
- Sudden shortness of breath
- Chest pain or pressure
- Unexplained pain, swelling or redness in an arm or leg
- Sudden weakness or numbness
- Difficulty speaking
- Severe dizziness or fainting
These symptoms shouldn’t be treated with a home remedy or simply waited out. (U.S. Food and Drug Administration)
❗ Don’t stop a prescription medication because of a viral headline
The correct action depends on which medicine you’re taking, why you’re taking it, your dose, and your individual risk factors. For example, the FDA specifically advises people taking tofacitinib not to stop it without first discussing it with their healthcare professional because stopping treatment can worsen the underlying condition. (U.S. Food and Drug Administration)
If you give me the name of the tablets (or upload a photo of the package), I can tell you exactly what the warning applies to, how serious the risk is, and what symptoms to watch for.
